Viewing Study NCT00034593


Ignite Creation Date: 2025-12-25 @ 1:24 AM
Ignite Modification Date: 2025-12-27 @ 10:49 PM
Study NCT ID: NCT00034593
Status: COMPLETED
Last Update Posted: 2006-07-19
First Post: 2002-04-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2 Trial of ALIMTA (Pemetrexed) Plus Gemcitabine in Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module